Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (49)
Natalya Eshchenko, Mariia Sergeeva, Evgenii Zhuravlev, Kira Kudria, Elena Goncharova, Andrey Komissarov & Grigory Stepanov. (2024) A Knockout of the IFITM3 Gene Increases the Sensitivity of WI-38 VA13 Cells to the Influenza A Virus. International Journal of Molecular Sciences 25:1, pages 625.
Crossref
Crossref
Elizabeth Mavil-Guerrero, Rafael Vazquez-Duhalt & Karla Juarez-Moreno. (2024) Exploring the cytotoxicity mechanisms of copper ions and copper oxide nanoparticles in cells from the excretory system. Chemosphere 347, pages 140713.
Crossref
Crossref
Chia‐Yu Chi, Ming‐Fang Cheng, Karam Ko, Joaquin F. Mould, Chih‐Jung Chen, Yhu‐Chering Huang & Ping‐Ing Lee. (2024) Cost‐effectiveness analysis of cell‐based versus egg‐based quadrivalent influenza vaccines in the pediatric population in Taiwan. Journal of Medical Virology 96:1.
Crossref
Crossref
João Rodrigues Correia Ramos, Thomas Bissinger, Yvonne Genzel & Udo Reichl. (2022) Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites 12:3, pages 239.
Crossref
Crossref
Jiamin Wang, Lixia Liu, Di Yang, Li Zhang, Ayimuguli Abudureyimu, Zilin Qiao & Zhongren Ma. (2022) Identification and differential expression of microRNAs in Madin–Darby canine kidney cells with high and low tumorigenicities. Genes & Genomics 44:2, pages 187-196.
Crossref
Crossref
Eve Versage, Esther van Twuijver, Wim Jansen, Ad Theeuwes, Daphne Sawlwin & Matthew Hohenboken. (2021) Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults. Vaccines 9:12, pages 1468.
Crossref
Crossref
Thomas Bissinger, Yixiao Wu, Pavel Marichal‐Gallardo, Dietmar Riedel, Xuping Liu, Yvonne Genzel, Wen‐Song Tan & Udo Reichl. (2021) Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering 118:10, pages 3996-4013.
Crossref
Crossref
Nurul Nadiah Zulkarnain, Nurina Anuar, Norliza Abd. Rahman, Siti Rozaimah Sheikh Abdullah, Muhammad Nazir Alias, Mashitoh Yaacob, Zhongren Ma & Gongtao Ding. (2021)
Cell-based influenza vaccine: current production,
halal
status assessment, and recommendations towards Islamic-compliant manufacturing
. Human Vaccines & Immunotherapeutics 17:7, pages 2158-2168.
Crossref
Crossref
Sabine Pech, Markus Rehberg, Robert Janke, Dirk Benndorf, Yvonne Genzel, Thilo Muth, Albert Sickmann, Erdmann Rapp & Udo Reichl. (2021) Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Applied Microbiology and Biotechnology 105:5, pages 1861-1874.
Crossref
Crossref
Xiaofeng Dai, Yujie Miao, Peiyu Han, Xuanhao Zhang, Siming Yang, Qing Lv & Dong Hua. (2021)
PABPC1
Enables Cells with the Suspension Cultivation Feature
. ACS Synthetic Biology 10:2, pages 309-317.
Crossref
Crossref
Daniela Marín‐Hernández, Robert E. Schwartz & Douglas F. Nixon. (2020) Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID‐19 deaths in Italy. Journal of Medical Virology 93:1, pages 64-65.
Crossref
Crossref
Constantina Boikos, Gregg C Sylvester, John S Sampalis & James A Mansi. (2020) Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018. Clinical Infectious Diseases 71:10, pages e665-e671.
Crossref
Crossref
Chung-Yi Wu, Hong-Yang Chuang & Chi-Huey Wong. (2020) Influenza virus neuraminidase regulates host CD8+ T-cell response in mice. Communications Biology 3:1.
Crossref
Crossref
Ana Filipa Rodrigues, Paulo Fernandes, Tanja Laske, Rute Castro, Paula Marques Alves, Yvonne Genzel & Ana Sofia Coroadinha. (2020) Cell Bank Origin of MDCK Parental Cells Shapes Adaptation to Serum-Free Suspension Culture and Canine Adenoviral Vector Production. International Journal of Molecular Sciences 21:17, pages 6111.
Crossref
Crossref
Giovanna Elisa Calabrò, Maria Lucia Specchia, Sara Boccalini, Donatella Panatto, Caterina Rizzo, Stefano Merler, Anna Maria Ferriero, Maria Luisa Di Pietro, Paolo Bonanni & Chiara de Waure. (2020) Strengthening the Evidence-Based Approach to Guiding Effective Influenza Vaccination Policies. Vaccines 8:3, pages 342.
Crossref
Crossref
Xiaofeng Dai, Xuanhao ZhangKostya OstrikovLevon Abrahamyan. (2020) Host receptors: the key to establishing cells with broad viral tropism for vaccine production. Critical Reviews in Microbiology 46:2, pages 147-168.
Crossref
Crossref
Francesca Maria Capellini, Walter Vencia, Massimo Amadori, Giulia Mignone, Erica Parisi, Lucia Masiello, Barbara Vivaldi, Angelo Ferrari & Elisabetta Razzuoli. (2019) Characterization of MDCK cells and evaluation of their ability to respond to infectious and non-infectious stressors. Cytotechnology 72:1, pages 97-109.
Crossref
Crossref
Thomas Bissinger, Johannes Fritsch, Adrian Mihut, Yixiao Wu, Xuping Liu, Yvonne Genzel, Wen-Song Tan & Udo Reichl. (2019) Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production. Vaccine 37:47, pages 7003-7010.
Crossref
Crossref
Kazuya Nakamura, Yuichi Harada, Hitoshi Takahashi, Heidi Trusheim, Roth Bernhard, Itsuki Hamamoto, Asumi Hirata-Saito, Teruko Ogane, Katsumi Mizuta, Nami Konomi, Yasushi Konomi, Hideki Asanuma, Takato Odagiri, Masato Tashiro & Norio Yamamoto. (2019) Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus. Vaccine 37:43, pages 6526-6534.
Crossref
Crossref
Bao-Yang Ruan, Feng Wen, Xiao-Qian Gong, Xiao-Min Liu, Qi Wang, Ling-Xue Yu, Shuai-Yong Wang, Peng Zhang, Hai-Ming Yang, Tong-Ling Shan, Hao Zheng, Yan-Jun Zhou, Wu Tong, Fei Gao, Guang-Zhi Tong & Hai Yu. (2018) Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs. Veterinary Microbiology 222, pages 75-84.
Crossref
Crossref
Emma Rey-Jurado, Felipe Tapia, Natalia Muñoz-Durango, Margarita K. Lay, Leandro J. Carreño, Claudia A. Riedel, Susan M. Bueno, Yvonne Genzel & Alexis M. Kalergis. (2018) Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution. Frontiers in Immunology 9.
Crossref
Crossref
Yun Ha Lee, Yo Han Jang & Baik Lin Seong. (2017) Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine. Virology 504, pages 73-78.
Crossref
Crossref
Lei Feng, Yinghua Tang, Peipei Wu, Xuan Chu, Weifeng Wang & Jibo Hou. (2016) H9 subtype influenza vaccine in MDCK single‐cell suspension culture with stable expression of TMPRSS2: Generation and efficacy evaluation. Engineering in Life Sciences 16:8, pages 795-807.
Crossref
Crossref
Sabine Kluge, Yvonne Genzel, Kim Laus, Anja Serve, Antje Pflugmacher, Britta Peschel, Erdmann Rapp & Udo Reichl. (2016) Ezrin and HNRNP expression correlate with increased virus release rate and early onset of virus‐induced apoptosis of MDCK suspension cells. Biotechnology Journal 11:10, pages 1332-1342.
Crossref
Crossref
Stephan Bart, Kevin Cannon, Darrell Herrington, Richard Mills, Eduardo Forleo-Neto, Kelly Lindert & Ahmed Abdul Mateen. (2016) Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. Human Vaccines & Immunotherapeutics 12:9, pages 2278-2288.
Crossref
Crossref
Asghar Abdoli, Hoorieh Soleimanjahi, Abbas Jamali, Parvaneh Mehrbod, Shima Gholami, Zahra Kianmehr, Neda Feizi, Maryam Saleh, Fariborz Bahrami, Talat Mokhtari-Azad, Mohsen Abdoli & Masoumeh Tavassoti Kheiri. (2016) Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production. Biotechnology Letters 38:6, pages 941-948.
Crossref
Crossref
Murielle André, Sylviane Reghin, Estelle Boussard, Laurent Lempereur & Stéphane Maisonneuve. (2016) Universal real-time PCR assay for quantitation and size evaluation of residual cell DNA in human viral vaccines. Biologicals 44:3, pages 139-149.
Crossref
Crossref
Robyn Hartvickson, Marilou Cruz, John Ervin, Donald Brandon, Eduardo Forleo-Neto, Alemnew F. Dagnew, Richa Chandra, Kelly Lindert & Ahmed Abdul Mateen. (2015) Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial. International Journal of Infectious Diseases 41, pages 65-72.
Crossref
Crossref
Françoise Aubrit, Fabien Perugi, Arnaud Léon, Fabienne Guéhenneux, Patrick Champion-Arnaud, Mehdi Lahmar & Klaus Schwamborn. (2015) Cell substrates for the production of viral vaccines. Vaccine 33:44, pages 5905-5912.
Crossref
Crossref
Sabine Kluge, Dirk Benndorf, Yvonne Genzel, Klaus Scharfenberg, Erdmann Rapp & Udo Reichl. (2015) Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension. Vaccine 33:35, pages 4269-4280.
Crossref
Crossref
Yvonne Genzel. (2015) Designing cell lines for viral vaccine production: Where do we stand?. Biotechnology Journal 10:5, pages 728-740.
Crossref
Crossref
V.H. Basavaraj, G. Sampath, Nagendra R. Hegde, V. Krishna Mohan & Krishna M. Ella. (2014) Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies. Vaccine 32:35, pages 4592-4597.
Crossref
Crossref
Nagendra R. Hegde, Deepak Kumar, P. Panduranga Rao, P. Krishna Kumari, Yashpal Kaushik, R. Ravikrishnan, Sai D. Prasad & Krishna M. Ella. (2014) Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India. Vaccine 32:29, pages 3636-3643.
Crossref
Crossref
Ingo Jordan & Volker Sandig. (2014) Matrix and Backstage: Cellular Substrates for Viral Vaccines. Viruses 6:4, pages 1672-1700.
Crossref
Crossref
Felipe Tapia, Thomas Vogel, Yvonne Genzel, Ilona Behrendt, Mark Hirschel, J. David Gangemi & Udo Reichl. (2014) Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine 32:8, pages 1003-1011.
Crossref
Crossref
Andrea Romero-Maldonado, Jorge A. Salazar-González & Sergio Rosales-Mendoza. 2014. Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases. Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases
129
139
.
Nani Wibowo, Yap P. Chuan, Linda H.L. Lua & Anton P.J. Middelberg. (2013) Modular engineering of a microbially-produced viral capsomere vaccine for influenza. Chemical Engineering Science 103, pages 12-20.
Crossref
Crossref
Vladimir Y. Lugovtsev, Darya Melnyk & Jerry P. Weir. (2013) Heterogeneity of the MDCK Cell Line and Its Applicability for Influenza Virus Research. PLoS ONE 8:9, pages e75014.
Crossref
Crossref
Hoang T. Phan, Julia Pohl, Doreen M. Floss, Frank Rabenstein, Jutta Veits, Binh T. Le, Ha H. Chu, Gerd Hause, Thomas Mettenleiter & Udo Conrad. (2013)
ELP
ylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against
H5N
1 viruses in mice
. Plant Biotechnology Journal 11:5, pages 582-593.
Crossref
Crossref
Jana Verena Rödig, Erdmann Rapp, Jana Bohne, Michael Kampe, Helene Kaffka, Andreas Bock, Yvonne Genzel & Udo Reichl. (2013)
Impact of cultivation conditions on
N
‐glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture
. Biotechnology and Bioengineering 110:6, pages 1691-1703.
Crossref
Crossref
Julia Hütter, Jana V. Rödig, Dirk Höper, Peter H. Seeberger, Udo Reichl, Erdmann Rapp & Bernd Lepenies. (2013)
Toward Animal Cell Culture–Based Influenza Vaccine Design: Viral Hemagglutinin
N-
Glycosylation Markedly Impacts Immunogenicity
. The Journal of Immunology 190:1, pages 220-230.
Crossref
Crossref
Yvonne Genzel, Ilona Behrendt, Jana Rödig, Erdmann Rapp, Claudia Kueppers, Stefan Kochanek, Gudrun Schiedner & Udo Reichl. (2012) CAP, a new human suspension cell line for influenza virus production. Applied Microbiology and Biotechnology 97:1, pages 111-122.
Crossref
Crossref
Thomas R. Talbot, Hilary Babcock, Deborah Cotton, Lisa L. Maragakis, Gregory A. Poland, Edward J. Septimus, Michael L. Tapper & David J. Weber. (2015) The Use of Live Attenuated Influenza Vaccine (LAIV) in Healthcare Personnel (HCP): Guidance from the Society for Healthcare Epidemiology of America (SHEA). Infection Control & Hospital Epidemiology 33:10, pages 981-983.
Crossref
Crossref
Humberto Reynales, Pedro Astudillo, Serge de Vallière, Christoph Hatz, Patricia Schlagenhauf, Barbara Rath, Priscilla Velentgas, Ariel Fariña, Victor Sales-Carmona & Nicola Groth. (2012) A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic. Vaccine 30:45, pages 6436-6443.
Crossref
Crossref
Zhi Sun, Victor C. Huber, Kara McCormick, Radhey S. Kaushik, Adrianus C. M. Boon, Longchao Zhu, Ben Hause, Richard J. Webby & Ying Fang. (2012) Characterization of a porcine intestinal epithelial cell line for influenza virus production. Journal of General Virology 93:9, pages 2008-2016.
Crossref
Crossref
B. Isken, Y. Genzel & U. Reichl. (2012) Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants. Vaccine 30:35, pages 5253-5261.
Crossref
Crossref
Jessica O. Josefsberg & Barry Buckland. (2012) Vaccine process technology. Biotechnology and Bioengineering 109:6, pages 1443-1460.
Crossref
Crossref
Holger Loessner, Astrid Schwantes, Matthias Hamdorf, Uliana Komor, Sara Leschner & Siegfried Weiss. 2012. Development of Novel Vaccines. Development of Novel Vaccines
87
124
.
Joseph D Dukes, Paul Whitley & Andrew D Chalmers. (2011) The MDCK variety pack: choosing the right strain. BMC Cell Biology 12:1.
Crossref
Crossref